A Study of Nivolumab in Selected Uterine Cancer Patients
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT03241745
- Phase
- PHASE2
- Status
- Completed
Conditions
- Carcinosarcoma
- Clear Cell Carcinoma
- Endometrial Carcinoma
- High Grade Endometrial Stromal Sarcoma
- Leiomyosarcoma
- Undifferentiated Sarcoma
- Uterine Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nivolumab — DRUGNivolumab 480 mg IV once every 4 weeks
Study Details
The purpose of this study is to test the safety of nivolumab and find out what affects, if any, nivolumab has on people and their risk of gynecologic cancer. The investigators also want to find out what effects, good or bad, nivolumab has on the patient and their cancer.
Key Dates
- Start date
- Aug 3, 2017
- Status verified
- Dec 2024
- Primary completion
- Apr 1, 2024
- Completion
- Apr 1, 2024
Study Design
- Enrollment
- 35 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: NivolumabNivolumab treatment: Nivolumab 480 mg IV once every 4 weeks. Treatment will continue until time of disease progression or until development of unacceptable toxicity, whichever comes first.
Primary Outcome Measure
Progression-Free Survival [ Time Frame: at 24 weeks ]
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | - |
| Lehigh Valley Health Network | Allentown | Pennsylvania | 18103 | - |
Find similar trials in Basking Ridge, NJ
By condition
By specialty
By research site
Related Studies
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)PHASE3 · Recruiting · Advenchen Laboratories, LLC · Phoenix, Arizona
- Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPHASE3 · Recruiting · European Organisation for Research and Treatment of Cancer - EORTC · Birmingham, Alabama
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama